Viewing Study NCT04634058


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-05-13 @ 5:52 AM
Study NCT ID: NCT04634058
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-16
First Post: 2020-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment
Sponsor: Shanghai Zhongshan Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cholangiocarcinoma, Intrahepatic View
None PD-L1 View
None CTLA4 View
Keywords: